1
Women's Health APEA Final Exam | Latest & Newest Update | Comprehensive
Study Guide | Practice Questions & Verified Answers | Detailed Rationales |
Women's Health Nurse Practitioner Exam Preparation | Instant PDF Download
Summary of Exam Coverage
This comprehensive examination covers the full scope of Women's Health APEA Final Exam
content, including:
1. Contraception - Combined and progestin-only methods, emergency contraception, IUDs,
implants, and injectables
2. Hormonal Therapy - Menopausal hormone therapy, PCOS management, endometriosis
treatment
3. Gynecologic Cancers - Cervical, endometrial, ovarian, and breast cancer screening,
diagnosis, and management
4. Infectious Diseases - STIs, PID, vaginitis, and their management
5. Menstrual Disorders - Abnormal uterine bleeding, dysmenorrhea, amenorrhea
6. Breast Health - Benign breast conditions, breast cancer screening, diagnosis, and
treatment
7. Reproductive Endocrinology - PCOS, premature ovarian failure, infertility
8. Pharmacology - Contraceptive medications, hormonal therapies, antimicrobials
9. Preventive Care - Screening guidelines, vaccination, risk reduction
10. Clinical Management - Patient counseling, treatment algorithms, follow-up care
,2
1. In the prevention of pregnancy, medroxyprogesterone acetate (Depo-Provera) should be
administered at least every:
A) 4 weeks
B) 8 weeks
C) 10 weeks
D) 12 weeks
Correct Answer: D) 12 weeks
Rationale: Depo-Provera injections must be administered every 11-13 weeks (ideally every 12
weeks) to maintain contraceptive effectiveness. The 13-week effectiveness window provides a 1-
week grace period for administration.
2. Patients taking oral contraceptives do NOT need to use a back-up method of contraception if
taking:
A) Ampicillin
B) Ketoconazole
C) Phenytoin (Dilantin)
D) Metformin (Glucophage)
Correct Answer: D) Metformin (Glucophage)
Rationale: Metformin does not interact with oral contraceptives. Antibiotics like ampicillin,
antifungals like ketoconazole, and anticonvulsants like phenytoin can reduce contraceptive
efficacy and require backup methods.
3. When initiating progestin-only contraceptives, women should be advised to:
A) Take with food anytime of the day
B) Resume with the next dose, if one dose is missed
C) Immediately report irregular uterine bleeding
D) Use a backup method of contraception for the first month
,3
Correct Answer: D) Use a backup method of contraception for the first month
Rationale: Progestin-only contraceptives require consistent use; a backup method is
recommended for the first month to ensure contraceptive efficacy while the body adjusts to the
hormonal regimen.
4. The drug of choice to control mild abnormal uterine bleeding in a 25-year-old woman with
future childbearing plans is:
A) Estrogen only
B) Androgen therapy
C) Gonadotropin-releasing hormone analogs
D) Progesterone only
Correct Answer: D) Progesterone only
Rationale: Progesterone-only therapy controls bleeding while preserving fertility. Combination
estrogen/progesterone is also appropriate, but progesterone-only is preferred when future
childbearing is desired.
5. The highest risk of deep vein thrombosis (DVT) is associated with combined estrogen and
progesterone therapy that is administered via:
A) The oral route
B) Transdermal patch
C) Intravaginal cream
D) Intravaginal ring
Correct Answer: A) The oral route
Rationale: Oral combination contraceptives carry the highest DVT risk due to first-pass hepatic
metabolism affecting clotting factors. Transdermal and vaginal routes have lower thrombotic
risk profiles.
, 4
6. Combined contraceptive patches:
A) Are replaced every 14 days
B) Have fewer side effects than oral contraceptives
C) May not be as effective in women weighing more than 200 pounds
D) Are safer than oral contraceptives in patients with hypertension
Correct Answer: C) May not be as effective in women weighing more than 200 pounds
Rationale: The contraceptive patch shows reduced efficacy in women weighing over 90 kg (198
pounds). It is applied weekly for 3 weeks with one patch-free week.
7. Danazol is indicated in the treatment of:
A) Ectopic pregnancy
B) Endometriosis
C) Gonadal hypertrophy
D) Ovulatory dysfunction
Correct Answer: B) Endometriosis
Rationale: Danazol, an androgen derivative, suppresses FSH and LH, creating a hypoestrogenic
state that reduces endometriotic lesions. It is not used for ectopic pregnancy, gonadal
hypertrophy, or ovulatory dysfunction.
8. Which of the following would NOT be an appropriate choice for the treatment of primary
dysmenorrhea in an 18-year-old woman?
A) Nonsteroidal anti-inflammatory medications
B) Oral contraceptives
C) Vitamin B6
D) Intrauterine devices
Correct Answer: D) Intrauterine devices
Rationale: While IUDs can help with dysmenorrhea, they are not first-line treatment and are
Women's Health APEA Final Exam | Latest & Newest Update | Comprehensive
Study Guide | Practice Questions & Verified Answers | Detailed Rationales |
Women's Health Nurse Practitioner Exam Preparation | Instant PDF Download
Summary of Exam Coverage
This comprehensive examination covers the full scope of Women's Health APEA Final Exam
content, including:
1. Contraception - Combined and progestin-only methods, emergency contraception, IUDs,
implants, and injectables
2. Hormonal Therapy - Menopausal hormone therapy, PCOS management, endometriosis
treatment
3. Gynecologic Cancers - Cervical, endometrial, ovarian, and breast cancer screening,
diagnosis, and management
4. Infectious Diseases - STIs, PID, vaginitis, and their management
5. Menstrual Disorders - Abnormal uterine bleeding, dysmenorrhea, amenorrhea
6. Breast Health - Benign breast conditions, breast cancer screening, diagnosis, and
treatment
7. Reproductive Endocrinology - PCOS, premature ovarian failure, infertility
8. Pharmacology - Contraceptive medications, hormonal therapies, antimicrobials
9. Preventive Care - Screening guidelines, vaccination, risk reduction
10. Clinical Management - Patient counseling, treatment algorithms, follow-up care
,2
1. In the prevention of pregnancy, medroxyprogesterone acetate (Depo-Provera) should be
administered at least every:
A) 4 weeks
B) 8 weeks
C) 10 weeks
D) 12 weeks
Correct Answer: D) 12 weeks
Rationale: Depo-Provera injections must be administered every 11-13 weeks (ideally every 12
weeks) to maintain contraceptive effectiveness. The 13-week effectiveness window provides a 1-
week grace period for administration.
2. Patients taking oral contraceptives do NOT need to use a back-up method of contraception if
taking:
A) Ampicillin
B) Ketoconazole
C) Phenytoin (Dilantin)
D) Metformin (Glucophage)
Correct Answer: D) Metformin (Glucophage)
Rationale: Metformin does not interact with oral contraceptives. Antibiotics like ampicillin,
antifungals like ketoconazole, and anticonvulsants like phenytoin can reduce contraceptive
efficacy and require backup methods.
3. When initiating progestin-only contraceptives, women should be advised to:
A) Take with food anytime of the day
B) Resume with the next dose, if one dose is missed
C) Immediately report irregular uterine bleeding
D) Use a backup method of contraception for the first month
,3
Correct Answer: D) Use a backup method of contraception for the first month
Rationale: Progestin-only contraceptives require consistent use; a backup method is
recommended for the first month to ensure contraceptive efficacy while the body adjusts to the
hormonal regimen.
4. The drug of choice to control mild abnormal uterine bleeding in a 25-year-old woman with
future childbearing plans is:
A) Estrogen only
B) Androgen therapy
C) Gonadotropin-releasing hormone analogs
D) Progesterone only
Correct Answer: D) Progesterone only
Rationale: Progesterone-only therapy controls bleeding while preserving fertility. Combination
estrogen/progesterone is also appropriate, but progesterone-only is preferred when future
childbearing is desired.
5. The highest risk of deep vein thrombosis (DVT) is associated with combined estrogen and
progesterone therapy that is administered via:
A) The oral route
B) Transdermal patch
C) Intravaginal cream
D) Intravaginal ring
Correct Answer: A) The oral route
Rationale: Oral combination contraceptives carry the highest DVT risk due to first-pass hepatic
metabolism affecting clotting factors. Transdermal and vaginal routes have lower thrombotic
risk profiles.
, 4
6. Combined contraceptive patches:
A) Are replaced every 14 days
B) Have fewer side effects than oral contraceptives
C) May not be as effective in women weighing more than 200 pounds
D) Are safer than oral contraceptives in patients with hypertension
Correct Answer: C) May not be as effective in women weighing more than 200 pounds
Rationale: The contraceptive patch shows reduced efficacy in women weighing over 90 kg (198
pounds). It is applied weekly for 3 weeks with one patch-free week.
7. Danazol is indicated in the treatment of:
A) Ectopic pregnancy
B) Endometriosis
C) Gonadal hypertrophy
D) Ovulatory dysfunction
Correct Answer: B) Endometriosis
Rationale: Danazol, an androgen derivative, suppresses FSH and LH, creating a hypoestrogenic
state that reduces endometriotic lesions. It is not used for ectopic pregnancy, gonadal
hypertrophy, or ovulatory dysfunction.
8. Which of the following would NOT be an appropriate choice for the treatment of primary
dysmenorrhea in an 18-year-old woman?
A) Nonsteroidal anti-inflammatory medications
B) Oral contraceptives
C) Vitamin B6
D) Intrauterine devices
Correct Answer: D) Intrauterine devices
Rationale: While IUDs can help with dysmenorrhea, they are not first-line treatment and are
